MICHELLE ROBBINS: Open Payments
NPI 1710227244 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 30 payments from 14 companies in 2025. Trend: 2023 $403 · 2024 $808 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $215 |
| AstraZeneca Pharmaceuticals LP | 5 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
| Calliditas Therapeutics US Inc. | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| OPKO Pharmaceuticals, LLC | 2 | $36 |
| ANI Pharmaceuticals, Inc. | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
| Ardelyx, Inc. | 1 | $24 |
Products named: Fabhalta, FARXIGA, JARDIANCE, TARPEYO, Kerendia, RAYALDEE, PURIFIED CORTROPHIN GEL, JYNARQUE.
Industry payments across AL — which companies pay providers there.
